Skip to main content
. Author manuscript; available in PMC: 2018 Nov 19.
Published in final edited form as: Clin Cancer Res. 2016 Jun 22;23(1):88–96. doi: 10.1158/1078-0432.CCR-16-0825

Fig. 1. Study workflow.

Fig. 1

112 patients with metastatic breast cancer were recruited to the study. Blood was collected and analysed for CTC count and total cfDNA levels in all 112 patients. In 5 patients with high CTC count individual CTCS were isolated by DEPArray and subjected to targeted NGS in comparison with matched cfDNA and primary tumour tissue where available.